Obstetrics & Gynecology Doctors in Parsons, KS Accepting Medicare

4 Obstetrics & Gynecology doctors found. Showing 1 - 4

Dr. Javine Horani Mclaughlin, MD, FACOG Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1902 S Hwy 59 Ste 301, Parsons, KS 67357 Phone: 620-820-5850    Fax: 620-820-5851

Dr. Frederick Tabi Okie, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1902 S Us Highway 59, Parsons, KS 67357 Phone: 620-421-4881    Fax: 620-421-9544

Dr. Roseanne M Olmstead, M.D. Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1902 S Hwy 59 Ste 301, Parsons, KS 67357 Phone: 620-820-5850    Fax: 620-820-5851

Sarohd Tang, OB GYN Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1902 S Hwy 59, Ste 6, Parsons, KS 67357 Phone: 620-421-2460    Fax: 620-421-2462

News Archive

Natural products: The source of nearly half of modern drugs

New technology for discovering antibiotics, anti-cancer drugs and other medicines inside soil microbes and other natural sources is reviving a treasure hunt that already has given humanity more than 50 percent of today's prescription drugs. This new era in "bioprospecting" is the topic of the cover story in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society.

Savient Pharmaceuticals resubmits KRYSTEXXA BLA

Savient Pharmaceuticals, Inc. announced that it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for KRYSTEXXA™ (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.

Hospital news: Mergers, acquisitions and delivery of care make news around nation

Hospitals in California, New York and across the nation deal with mergers, acquisitions, delivery of care and fines in the marketplace. In the meantime, doctors whose practices were purchased by hospital chains feel increasing pressure to meet financial goals.

New MS treatment found safe, tolerable in phase I clinical trials

A new treatment under investigation for multiple sclerosis (MS) is safe and tolerable in phase I clinical trials, according to a study published August 27, 2014, in Neurology Neuroimmunology & Neuroinflammation, a new online-only, freely accessible, specialty medical journal.

Read more Medical News

› Verified 8 days ago